Skip to content

Galvanize Therapeutics

Pulsed electric field devices for soft tissue ablation

Raised to date

$136.2M

of $136.2M offered across 1 Form D filing

Investors
26
Last filed
Nov 18, 2026

About

Galvanize Therapeutics designs pulsed electric field (PEF) energy devices for the surgical ablation of soft tissue, focused on oncology and chronic disease. Its Aliya PEF System is 510(k) cleared in the US for soft tissue ablation, and its RheOx system is under investigation for chronic bronchitis. The company was formed in 2022 through the merger of Gala Therapeutics and Galaxy Medical and is based in Redwood City, California.

The Aliya EX PEF System is described as the only soft tissue ablation system FDA cleared for both endoscopic and percutaneous approaches.

Funding

  • EquityFiled Nov 18, 2026Form D
    $136.2M/ $136.2M

Product

Aliya EX PEF System

Medical device

A pulsed electric field generator with compatible needle delivery devices, cleared by the FDA for surgical ablation of soft tissue.

  • 510(k) cleared for surgical ablation of soft tissue
  • Cleared for endoscopic and percutaneous approaches
  • Aliya EX generator with compatible delivery devices

Built for

Physicians and hospitals performing soft tissue ablation, including oncology and interventional specialists

People on file